WNT2 and liver cancer: Elevated lncRNA-DAW mediated the degradation of EZH2 (a negative regulatory factor of WNT2), and WNT2 activated Wnt/β-catenin pathway after it’s removed inhibition, which promotes the progression of liver cancer [79].